End-to-end bioinformatics

Seven Bridges is the leading biomedical data analysis company, specializing in software for genomics-based research and development for new therapeutics and diagnostics.

We deliver end-to-end bioinformatics solutions, designed to speed the path from raw experimental data to actionable results. Our tools are used by thousands of researchers in biotech, pharmaceutical, and academic labs, as well as some of the world’s largest national genomics research programs including at the National Cancer Institute and the U.S. Department of Veterans Affairs.

Collaboration

Seven Bridges software connects global teams and data to enable collaborative research and development, acting as the unifying environment for biomedical data analysis.

DISCOVERY

Our products support scientific discovery with streamlined data management, rapid querying of omics data, deployment of new methods, and fully reproducible analysis.

DATA & COMPUTE

Our systems build on the capabilities of leading cloud and HPC infrastructures, giving immediate access to scalable computation, centralized data storage and key public datasets.

SECURITY & COMPLIANCE

Comprehensive, integrated security features keep genomic information safe throughout the data life cycle, enhancing the implementation of advanced regulatory requirements.

Collaboration

Seven Bridges software connects global teams and data to enable collaborative research and development, acting as the unifying environment for biomedical data analysis.

DISCOVERY

Our products support scientific discovery with streamlined data management, rapid querying of omics data, deployment of new methods, and fully reproducible analysis.

DATA & COMPUTE

Our systems build on the capabilities of leading cloud and HPC infrastructures, giving immediate access to scalable computation, centralized data storage and key public datasets.

SECURITY & COMPLIANCE

Comprehensive, integrated security features keep genomic information safe throughout the data life cycle, enhancing the implementation of advanced regulatory requirements.

Our Platform enables research teams to learn from the world’s genomic data

Find out more